Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke imaging at 3.0 T.

M Louis Lauzon1, Robert J Sevick, Andrew M Demchuk

  • 1University of Calgary, Calgary, Alberta, Canada. mllauzon@ucalgary.ca

Neuroimaging Clinics of North America
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intravenous Thrombolysis at Primary Stroke Centers Versus Comprehensive Stroke Centers: Analysis From the AcT Trial.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Asundexian for Secondary Stroke Prevention.

The New England journal of medicine·2026
Same author

MRI measurement of the delayed secondary ischaemic injury following endovascular thrombectomy: results from the REPERFUSE-NA1 study.

European stroke journal·2026
Same author

Intracranial CTA-for-All Nontraumatic ICH.

Cerebrovascular diseases (Basel, Switzerland)·2026
Same author

Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026
Same author

Reperfusion grade and clinical outcome following medium vessel occlusion thrombectomy in the Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusions (ESCAPE-MeVO) trial.

Journal of neurointerventional surgery·2026
Same journal

Understanding Acute Encephalopathy.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Acute Encephalopathies.

Neuroimaging clinics of North America·2026
Same journal

Pediatric Encephalopathy: Inflammatory and Autoimmune Etiologies.

Neuroimaging clinics of North America·2026
Same journal

Pediatric Encephalopathy: Inherited Metabolic Disorders.

Neuroimaging clinics of North America·2026
Same journal

Post-Treatment Causes of Encephalopathy.

Neuroimaging clinics of North America·2026
Same journal

Acute Toxic Leukoencephalopathy: Opioid and other Illicit or Abused Drugs and Environmental Toxins.

Neuroimaging clinics of North America·2026
See all related articles

High-field 3.0 T MRI offers improved diagnostic imaging for stroke, a leading cause of death and disability. This technology enhances anatomical and functional assessments, potentially reducing scan times compared to 1.5 T scanners.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Stroke is a significant cause of mortality and long-term disability in North America.
  • Accurate diagnosis and characterization of stroke require advanced Magnetic Resonance (MR) imaging techniques.
  • The development of higher field strength MR scanners presents new opportunities for stroke imaging.

Purpose of the Study:

  • To provide an overview of stroke pathophysiology.
  • To explain the principles and clinical applications of key MR techniques for stroke diagnosis.
  • To discuss the benefits and drawbacks of using 3.0 T MR scanners for stroke imaging.

Main Methods:

  • Review of specialized MR techniques: diffusion-weighted imaging (DWI), MR angiography (MRA), and perfusion-weighted imaging (PWI).

Related Experiment Videos

  • Comparison of 3.0 T MR imaging protocols with traditional 1.5 T protocols for stroke assessment.
  • Discussion of high-field imaging principles relevant to diagnostic stroke imaging.

    • Main Results:

    • 3.0 T scanners offer the potential for higher quality imaging data in stroke patients.
    • Higher field strength may allow for reduced scan times in stroke-specific MR imaging protocols.
    • Specific advantages, challenges, and limitations of 3.0 T imaging in the context of stroke are identified.

    Conclusions:

    • 3.0 T MR imaging holds promise for enhancing the diagnostic capabilities in stroke evaluation.
    • Understanding the principles and applications of advanced MR techniques at 3.0 T is crucial for effective stroke management.
    • Further evaluation of 3.0 T imaging is warranted to optimize its role in clinical stroke protocols.